Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (181-190 of 245) with videos related to

Pageof 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Local control with multimodality therapy for stage 4 neuroblastomaS L Wolden, S V Gollamudi, B H Kushner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastomaVictoria J Croog, Kim Kramer, Nai-Kong V Cheung, et al.
Cancers|December 24, 2021
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk NeuroblastomaFiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, et al.
Electromyography and Clinical Neurophysiology|December 1, 1991
Clinical and electrophysiological assessments in ALS patientsA J Tahmoush, J A Gillespie, J F Hulihan, et al.
JAMA Oncology|December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical TrialIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2018
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?Dana L Casey, Ken L Pitter, Brian H Kushner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastomaK Kramer, N K Cheung, W L Gerald, et al.
The Journal of Molecular Diagnostics : JMD|March 29, 2001
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1pJ Mora, N K Cheung, B H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
Pageof 25

Showing results (181-190 of 245) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Local control with multimodality therapy for stage 4 neuroblastomaS L Wolden, S V Gollamudi, B H Kushner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 9, 2010
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastomaVictoria J Croog, Kim Kramer, Nai-Kong V Cheung, et al.
Cancers|December 24, 2021
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk NeuroblastomaFiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, et al.
Electromyography and Clinical Neurophysiology|December 1, 1991
Clinical and electrophysiological assessments in ALS patientsA J Tahmoush, J A Gillespie, J F Hulihan, et al.
JAMA Oncology|December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical TrialIrene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2018
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?Dana L Casey, Ken L Pitter, Brian H Kushner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastomaK Kramer, N K Cheung, W L Gerald, et al.
The Journal of Molecular Diagnostics : JMD|March 29, 2001
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1pJ Mora, N K Cheung, B H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete RemissionBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.
Cancer|April 3, 2014
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary eraBrian H Kushner, Shakeel Modak, Kim Kramer, et al.
Pageof 25